The case of the day is In re Schlich (D. Mass. 2016). It arises out of competing claims to invention of CRISPR/Cas9, a new gene editing technology that has gotten a lot of attention in the popular press. Jennifer Doudna of UC Berkeley and her collaborator, Emmanuelle Charpentier, claimed to be the inventors, and Doudna’s company, Intellia Therapeutics, brought an opposition proceeding in Europe seeking to invalidate patents obtained there by the Broad Institute, listing another group of putative inventors, Feng Zhang, Le Cong, Patrick Hsu, and Fei Ran.
Tagged: 1782, European Patent Office, European Union